Pembrolizumab on pre-existing inclusion body myositis: a case report

BACKGROUND: Cases of exacerbation of pre-existing neuromuscular diseases induced by immune checkpoint inhibitors (ICIs) have rarely been reported because patients with autoimmune diseases have generally been excluded from ICI therapy due to the increased risk of exacerbation. We describe the first c...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchio, Naohiro, Unuma, Atsushi, Kakumoto, Toshiyuki, Osaki, Masao, Zenke, Yoshitaka, Sakuta, Kenichi, Kubota, Akatsuki, Uesaka, Yoshikazu, Toda, Tatsushi, Shimizu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493364/
https://www.ncbi.nlm.nih.gov/pubmed/32944686
http://dx.doi.org/10.1186/s41927-020-00144-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493364/
https://www.ncbi.nlm.nih.gov/pubmed/32944686
http://dx.doi.org/10.1186/s41927-020-00144-5

Ejemplares similares